Significant Increase in INPI Official Fees as from April 1, 2026
The Argentine Patent and Trademark Office has implemented an increase of approximately 100% and introduced a new adjustment system tied to inflation.
New patent landscape in Argentina: Practical Takeaways for Applicants
First Step in a Broader Shift Toward International IP Standards
Argentina removes restrictions on pharmaceutical and chemical patent applications
A major milestone for the Argentine patent system and a very welcome piece of news for applicants.
Entry into force of the Nice Classification – 13th Edition as of January 1, 2026
The Argentine National Institute of Industrial Property (INPI) has announced that the 13th Edition of the Nice Classification will enter into force on January 1, 2026.
Important: Changes in the Trademark Law in Argentina – INPI Resolution 583/2025
The National Institute of Industrial Property (INPI) published on December 11th Resolution 583/2025, which introduces—once again—substantial modifications to the trademark registration procedure in Argentina, with the stated intention of streamlining the process, shortening timelines, and aligning our system with international standards.
Argentina– United Statements Agreement (ARTI): Impact on Patent Prosecution in Argentina
The Agreement includes a number of commitments that, if implemented, could substantially modify the current patent landscape, particularly in sectors such as pharmaceuticals, chemicals and biotechnology.
Palacio & Asociados is now PALACIO IP
In a world where ideas, trademarks and innovation are becoming increasingly valuable, we want our name to clearly reflect what we do best
Crackdown on “La Salada” – Argentina’s Largest Black Market
The Argentine government has launched a major crackdown on La Salada, the country’s largest informal marketplace
Patentability Under Scrutiny: International Pressure on Argentina’s Patent Rules
In its latest report on trade barriers, the U.S. government once again highlighted concerns over Argentina’s Joint Ministerial Resolution 118/2012, which significantly restricts the patentability of chemical and pharmaceutical inventions.
New recognition for our team: GOLD TIER in IAM Patent 1000!
We are proud to announce that our patent team has been ranked in the Gold Tier, according to the IAM Patent 1000 ranking. A big thank you to our clients, colleagues, and entire team for their continued trust and daily commitment.